179062-05-6 Usage
Uses
Used in Pharmaceutical Industry:
5-AMINO-2-FLUORO-4-NITROBENZOTRIFLUORIDE is used as a key intermediate in the synthesis of various pharmaceuticals due to its strong electron-withdrawing properties, which facilitate the development of new drug molecules with improved efficacy and safety profiles.
Used in Agrochemical Industry:
In the agrochemical sector, 5-AMINO-2-FLUORO-4-NITROBENZOTRIFLUORIDE is utilized as a building block for the production of agrochemicals, contributing to the development of innovative and effective crop protection agents.
Used in Dye and Pigment Synthesis:
5-AMINO-2-FLUORO-4-NITROBENZOTRIFLUORIDE is employed as a reagent in the synthesis of dyes and pigments, enabling the creation of a wide range of colorants for various applications, including textiles, plastics, and printing inks.
Used in Organic Synthesis:
As a versatile building block in organic synthesis, 5-AMINO-2-FLUORO-4-NITROBENZOTRIFLUORIDE is used for the preparation of a variety of organic compounds, including those with potential applications in materials science, chemical research, and specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 179062-05-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,9,0,6 and 2 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 179062-05:
(8*1)+(7*7)+(6*9)+(5*0)+(4*6)+(3*2)+(2*0)+(1*5)=146
146 % 10 = 6
So 179062-05-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H4F4N2O2/c8-4-2-6(13(14)15)5(12)1-3(4)7(9,10)11/h1-2H,12H2
179062-05-6Relevant articles and documents
2-Substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
-
Page/Page column 34, (2010/02/11)
The present invention discloses compounds of formula I wherein Ar, X, R1 and R11 are herein defined, said compounds being novel antagonists for melanin-concentrating hormone (MCH), as well as methods for preparing such compounds. In
Glycine receptor antagonists and the use thereof
-
, (2008/06/13)
Methods of treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia and surgery, as well as treating neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease and Down's syndrome, treating or preventing the adverse consequences of the hyperactivity of the excitatory amino acids, as well as treating anxiety, chronic pain, convulsions, inducing anesthesia and treating psychosis are disclosed by administering to an animal in need of such treatment a compound having high affinity for the glycine binding site, lacking PCP side effects and which crosses the blood brain barrier of the animal. Also disclosed are novel 1,4-dihydroquinoxaline-2,3-diones, and pharmaceutical compositions thereof. Also disclosed are highly soluble ammonium salts of 1,4-dihydroquinoxaline-2,3-diones.
